BALBONI, Gianfranco
 Distribuzione geografica
Continente #
NA - Nord America 1.826
EU - Europa 517
AS - Asia 389
OC - Oceania 3
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.738
Nazione #
US - Stati Uniti d'America 1.825
CN - Cina 219
UA - Ucraina 146
DE - Germania 121
TR - Turchia 98
GB - Regno Unito 71
IT - Italia 60
SG - Singapore 59
SE - Svezia 51
FI - Finlandia 32
PL - Polonia 11
FR - Francia 10
RU - Federazione Russa 4
BE - Belgio 3
CZ - Repubblica Ceca 3
AU - Australia 2
HK - Hong Kong 2
ID - Indonesia 2
IN - India 2
KR - Corea 2
VN - Vietnam 2
BN - Brunei Darussalam 1
BR - Brasile 1
CA - Canada 1
CH - Svizzera 1
CL - Cile 1
EU - Europa 1
IE - Irlanda 1
IQ - Iraq 1
IR - Iran 1
NL - Olanda 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
RO - Romania 1
Totale 2.738
Città #
Houston 218
Fairfield 211
Woodbridge 196
Jacksonville 167
Chandler 151
Ann Arbor 131
Ashburn 125
Wilmington 80
Cambridge 68
Beijing 64
Seattle 62
Nanjing 54
Izmir 40
Singapore 37
Milan 34
Princeton 34
San Diego 25
Bremen 23
Boardman 21
Shanghai 17
Dearborn 16
Nanchang 16
San Mateo 14
Jinan 11
Los Angeles 11
Santa Clara 10
Shenyang 10
Warsaw 10
Ferrara 8
Zhengzhou 7
Indiana 6
Jiaxing 6
Tianjin 6
Addison 5
Kilburn 5
Mountain View 5
New York 5
Washington 5
Auburn Hills 4
Changsha 4
Norwalk 4
Philadelphia 4
Redwood City 4
Bologna 3
Brussels 3
Falls Church 3
Kunming 3
Acton 2
Antea 2
Cagliari 2
Cosenza 2
Dong Ket 2
Fremont 2
Guangzhou 2
Haikou 2
Hebei 2
Helsinki 2
Hong Kong 2
Jakarta 2
Ningbo 2
Redmond 2
San Francisco 2
Taizhou 2
Tappahannock 2
Verona 2
Albert Park 1
Amsterdam 1
Auckland 1
Augusta 1
Bandar Seri Begawan 1
Baotou 1
Canberra 1
Changchun 1
Chicago 1
Des Moines 1
Dublin 1
Düsseldorf 1
Edinburgh 1
Hounslow 1
Jinhua 1
Lanzhou 1
Leawood 1
Leipzig 1
London 1
Munich 1
New Bedfont 1
North Charleston 1
Olomouc 1
Orange 1
Osasco 1
Oslo 1
Prague 1
Prescot 1
Taiyuan 1
Wandsworth 1
Yellow Springs 1
Totale 2.013
Nome #
A CYCLIC PEPTIDE T ANALOGUE WITH HIGH CHEMOTACTIC ACTIVITY 151
Design, synthesis and evaluation of antiproliferative activity of new benzimidazolehydrazones 150
Design, Synthesis, DNA Binding, and Biological Evaluation of Water-Soluble Hybrid Molecules Containing Two Pyrazole Analogues of the Alkylating Cyclopropylpyrroloindole (CPI) Subunit of the Antitumor Agent CC-1065 and Polypyrrole Minor Groove Binders. 142
Synthesis, in vitro antiproliferative activity, and DNA-binding properties of hybrid molecules containing pyrrolo[2,1-c][1,4] benzodiazepine and minor-groove-binding oligopyrrole carriers 139
Acid catalysis in the formation of dioxopiperazines from peptides containing tetrahydroisoquinoline‐3‐carboxylic acid at position 2 132
Critical role for prokineticin 2 in CNS autoimmunity 113
Design of d-opioid peptide antagonists for emerging drug applications 112
Crystal structures of dipeptides containing the Dmt-Tic pharmacophore 110
Opioid diketopiperazines: Synthesis and activity of a prototypic class of opioid antagonists 108
Hydrogen sulfide induced disruption of Na+ homeostasis in the cortex 100
Assessment of substitution in the second pharmacophore of Dmt-Tic analogues 98
Synthesis and pharmacological activity of deltorphin and dermorphin-related glycopeptides 96
null 90
Tritiation of delta opioid-receptor selective antagonist dipeptide ligands with extraordinary affinity containing 2 ', 6 ' dimethyltyrosine 87
Characterization of N,N(Me)(2)-Dmt-Tic-OH, a delta selective opioid dipeptide antagonist 86
Evaluation of the Dmt-Tic pharmacophore: Conversion of a potent delta-opioid receptor antagonist into a potent delta agonist and ligands with mixed properties 80
Design and solution structure of a partially rigid opioid antagonist lacking the basic center - Models of antagonism 79
Conformational analysis of potent and very selective delta opioid dipeptide antagonists 78
Design of μ selective opioid dipeptide antagonists 72
Peptidic delta opioid receptor agonists produce antidepressant-like effects in the forced swim test amd regulate BDNF mRNA expression in rats. 70
Opioid diketopiperazines: Refinement of the delta opioid antagonist pharmacophore 68
Inhibition of human multidrug resistance P-glycoprotein 1 by analogues of a potent delta-opioid antagonist 68
Further Studies on the Dmt-Tic Pharmacophore: Hydrophobic Substituents at the C-Terminus Endow delta Antagonists To Manifest mu Agonism or mu Antagonism 66
Delta-, but not mu-, opioid receptor stabilize K+ homeostasis by reducing Ca2+ influx in the cortex during acute hypoxia. 64
Inverse agonism by Dmt-Tic analogues and H5 378, a naltrindole analogue 63
In vitro and in vivo pharmacological profile of UFP-512, a novel selective delta-opioid receptor agonist, correlation between desensitization and tolerance. 63
DMT-TIC-OH, a highly selective and potent delta-opioid dipeptide receptor antagonist after systemic administration in the mouse 62
Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary δ opioid antagonist activity 61
Potent delta-opioid receptor agonists containing the Dmt-Tic pharmacophore 55
null 46
Synthesis, metabolic stability and chemotactic activity of peptide T and its analogues 27
Synthesis and opioid activity of N,N-dimethyl-Dmt-Tic-NH-CH(R)-R ' analogues: Acquisition of potent delta antagonism 16
Opioid pseudopeptides containing heteroaromatic or heteroaliphatic nuclei 11
Totale 2.763
Categoria #
all - tutte 12.875
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.875


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020475 0 0 0 79 36 85 57 59 34 75 40 10
2020/2021386 33 32 8 60 7 39 18 41 11 52 61 24
2021/2022324 8 34 35 21 28 9 14 16 16 21 22 100
2022/2023372 33 8 21 43 73 45 32 41 37 3 16 20
2023/2024173 12 33 13 6 11 37 13 12 1 5 1 29
2024/202578 17 11 50 0 0 0 0 0 0 0 0 0
Totale 2.763